长春安沃高新生物制药有限公司成立于二零一九年三月,是由长春高新技术产业(集团)股份有限公司与冰岛Alvotech. hf(安沃泰克)合资建立的集研发、生产、销售于一体的高新技术企业。长春高新与安沃泰克成立合资公司,旨在研发、生产和销售面向国内外市场高品质的生物类似药产品,打造单克隆抗体类国际生物产业平台。合资公司将利用先进技术和高标准的质量管控体系、产业化的人才团队,按照NMPA、美国FDA和欧盟EMA的GMP标准建成高端生物药产业化生产基地。安沃高新致力于为世界各地的医疗机构带来源源不断的、患者能够负担起的高端生物药。 Alvotech & CCHT Biopharmaceutical Co., Ltd. (JV) was jointly established in March 2019 between Changchun High & New Technology Industries (Group) Inc.(CCHT)and Alvotech.Hf (Alvotech). CCHT and Alvotech Hf. established a joint venture company CAHT with the aim of developing, producing, and selling high-quality biosimilar products for domestic and foreign markets, and creating an international biological industry platform for monoclonal antibodies. JV is going to use advanced technology and high-standard quality control system, industrialized talent team, built a high-end biopharmaceutical industrialized production base in accordance with the GMP standards of NMPA, FDA and EMA.CAHT is committed to bringing a continuous source of high-end biological drugs that patients can afford to medical institutions around the world.

查看全部
职位

地址或联系信息

  • 长春市高新开发区长春北湖科技园产业一期
  • 未公布
  • 未公布
  • 未公布

登录查看地址或联系信息

登录/注册

热门招聘官

  • 薪酬福利主管

    2个职位

  • 人力资源专员

    2个职位